In Brief: Pharmacia Biotech
This article was originally published in The Gray Sheet
Executive Summary
Pharmacia Biotech: Gains non-exclusive worldwide license to Hoffmann-La Roche's polymerase chain reaction (PCR) technology for research uses. The license gives Pharmacia Biotech "the rights to manufacture and sell Taq DNA polymerase and other thermostable enzymes" under development for use in performing PCR, and also allows the firm to develop Ready-To-Go PCR beads, the firm states...